Ron Lanton Featured in Reuters on Global Drug Pricing and Market Strategy
Ron Lanton was recently quoted in Reuters on how U.S. drug pricing policy is influencing global pharmaceutical launch strategy and cross-border market dynamics.
Recent coverage in Reuters highlights how U.S. pricing policy is beginning to influence global launch strategy for pharmaceutical companies.
The article examines how manufacturers are adjusting decisions across markets in response to policy pressure and evolving reimbursement dynamics. Click here to view the article.